Most bought healthcare stocks in Q4 2025
Discover which Healthcare stocks institutional investors added to most aggressively over Q4 2025 versus the prior calendar quarter in our filings. Notable additions at the top of this list include PFIZER INC (PFE), MERCK & CO. INC. (MRK), JOHNSON & JOHNSON (JNJ), BRISTOL-MYERS SQUIBB CO (BMY). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Net share increases
Top symbols by net quarter-over-quarter share change (increases).
Most bought stocks
Net quarter-over-quarter share increases across all institutional filers.
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| PFE | PFIZER INC | 3,128,352,889 | $74.9B | 2783 | 18 | 15 | 3 | 2822 |
| MRK | MERCK & CO. INC. | 1,685,865,920 | $168.6B | 3443 | 11 | 21 | 1 | 3484 |
| JNJ | JOHNSON & JOHNSON | 1,589,090,444 | $303.4B | 4333 | 17 | 25 | 2 | 4386 |
| BMY | BRISTOL-MYERS SQUIBB CO | 1,389,994,664 | $71.9B | 2336 | 12 | 13 | 2 | 2368 |
| ABT | ABBOTT LABORATORIES | 1,224,860,412 | $140.2B | 3123 | 13 | 13 | 3 | 3163 |
| BSX | BOSTON SCIENTIFIC CORP | 1,188,171,781 | $107.8B | 1705 | 9 | 9 | 2 | 1728 |
| ABBV | ABBVIE INC | 1,126,754,191 | $247.1B | 3917 | 18 | 19 | 4 | 3964 |
| GILD | GILEAD SCIENCES INC | 921,925,374 | $106.7B | 2111 | 13 | 10 | 0 | 2141 |
| CVS | CVS HEALTH CORP | 911,462,883 | $69.7B | 1854 | 11 | 13 | 2 | 1884 |
| VTRS | VIATRIS INC | 828,712,145 | $9.0B | 951 | 4 | 5 | 0 | 965 |
| LLY | ELI LILLY & CO | 701,306,325 | $715.8B | 4249 | 19 | 16 | 1 | 4291 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 676,201,126 | $16.6B | 603 | 2 | 5 | 2 | 613 |
| UNH | UNITEDHEALTH GROUP INC | 629,148,812 | $193.2B | 3114 | 19 | 30 | 1 | 3173 |
| DHR | DANAHER CORP | 499,270,484 | $107.0B | 2194 | 12 | 13 | 2 | 2227 |
| AZN | ASTRAZENECA PLC-SPONS ADR | 478,547,840 | $38.8B | 1302 | 4 | 6 | 0 | 1315 |
| AVTR | AVANTOR INC | 473,467,585 | $5.0B | 396 | 4 | 6 | 2 | 406 |
| GERN | GERON CORP | 441,238,831 | $626.1M | 253 | 0 | 1 | 0 | 255 |
| EW | EDWARDS LIFESCIENCES CORP | 429,318,407 | $35.4B | 1242 | 6 | 7 | 1 | 1259 |
| CNC | CENTENE CORP | 411,684,008 | $16.1B | 873 | 7 | 3 | 0 | 886 |
| HLN | HALEON PLC-ADR | 407,443,428 | $4.3B | 576 | 5 | 3 | 1 | 588 |
| ELAN | ELANCO ANIMAL HEALTH INC | 388,781,876 | $8.4B | 460 | 1 | 3 | 0 | 467 |
| BAX | BAXTER INTERNATIONAL INC | 383,917,710 | $6.2B | 666 | 7 | 6 | 0 | 685 |
| AMGN | AMGEN INC | 378,597,922 | $119.7B | 2954 | 13 | 18 | 4 | 2991 |
| ZTS | ZOETIS INC | 365,112,730 | $41.1B | 1577 | 8 | 11 | 5 | 1601 |
| GEHC | GE HEALTHCARE TECHNOLOGY | 356,190,483 | $25.6B | 1248 | 10 | 8 | 1 | 1272 |
| LFST | LIFESTANCE HEALTH GROUP INC | 353,759,988 | $2.5B | 195 | 2 | 1 | 0 | 198 |
| AGL | AGILON HEALTH INC | 351,340,516 | $239.0M | 184 | 2 | 1 | 0 | 187 |
| TMO | THERMO FISHER SCIENTIFIC INC | 337,972,690 | $165.2B | 2580 | 13 | 15 | 0 | 2616 |
| GSK | GSK PLC-SPON ADR | 312,853,278 | $14.1B | 935 | 5 | 8 | 0 | 955 |
| DXCM | DEXCOM INC | 307,630,453 | $19.7B | 877 | 3 | 7 | 3 | 890 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | 306,933,197 | $14.7B | 1355 | 11 | 8 | 1 | 1376 |
| FOLD | AMICUS THERAPEUTICS INC | 284,379,804 | $4.0B | 317 | 1 | 2 | 0 | 321 |
| ISRG | INTUITIVE SURGICAL INC | 264,754,758 | $136.7B | 2281 | 22 | 5 | 0 | 2314 |
| MRNA | MODERNA INC | 262,326,296 | $7.7B | 637 | 2 | 6 | 0 | 649 |
| SYK | STRYKER CORP | 260,720,407 | $84.6B | 2219 | 12 | 17 | 0 | 2252 |
| BDX | BECTON DICKINSON AND CO | 260,651,012 | $38.8B | 1485 | 7 | 5 | 0 | 1502 |
| TSHA | TAYSHA GENE THERAPIES INC | 255,343,568 | $1.4B | 187 | 0 | 0 | 0 | 188 |
| LXRX | LEXICON PHARMACEUTICALS INC | 248,571,275 | $283.7M | 117 | 0 | 1 | 0 | 118 |
| RXRX | RECURSION PHARMACEUTICALS-A | 243,278,182 | $957.3M | 315 | 3 | 1 | 0 | 320 |
| SHC | SOTERA HEALTH CO | 236,341,763 | $4.1B | 271 | 0 | 1 | 0 | 274 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 234,181,565 | $619.6M | 256 | 1 | 0 | 0 | 257 |
| IVVD | INVIVYD INC | 229,448,956 | $565.7M | 113 | 0 | 0 | 0 | 114 |
| LAB | STANDARD BIOTOOLS INC | 223,514,913 | $284.1M | 149 | 1 | 0 | 0 | 151 |
| BHC | BAUSCH HEALTH COS INC | 222,551,254 | $1.5B | 225 | 4 | 0 | 2 | 230 |
| EXEL | EXELIXIS INC | 217,055,381 | $9.0B | 650 | 3 | 5 | 1 | 660 |
| A | AGILENT TECHNOLOGIES INC | 212,788,415 | $27.3B | 1081 | 6 | 4 | 1 | 1098 |
| VRTX | VERTEX PHARMACEUTICALS INC | 208,096,684 | $91.5B | 1585 | 10 | 8 | 1 | 1606 |
| CI | THE CIGNA GROUP | 200,797,477 | $52.0B | 1571 | 9 | 5 | 1 | 1594 |
| BKD | BROOKDALE SENIOR LIVING INC | 200,233,195 | $2.2B | 225 | 3 | 1 | 0 | 229 |
| ADMA | ADMA BIOLOGICS INC | 196,410,934 | $3.4B | 341 | 1 | 1 | 1 | 344 |